Reducing drug trafficking revenues and violence in Mexico : would legalizing marijuana in California help? / / Beau Kilmer, Jonathan P. Caulkins, Brittany M. Bond.

• Author: Rand Corporation.; Kilmer, Beau.
• TeilnehmendeR: Caulkins, Jonathan P.; Bond, Brittany M.; Rand Corporation.; Drug Policy Research Center (U.S.)
• Year of Publication: 2010
• Language: English
• Series: Occasional paper Reducing drug trafficking revenues and violence in Mexico
• Physical Description: 1 online resource (127 p.)
• Notes: Description based upon print version of record.

U.S. demand for illicit drugs creates markets for Mexican drug- trafficking organizations (DTOs) and helps foster violence in Mexico. This paper examines how marijuana legalization in California might influence DTO revenues and the violence in Mexico.

Table of Contents

Cover; Title Page; Copyright; Preface; Contents; Figures; Tables; Acknowledgments; Abbreviations; CHAPTER ONE: Introduction; CHAPTER TWO: Methods for Estimating Drug-Trafficking Organizations' Drug Revenues; Current Approaches for Estimating the Size of U.S. Drug Markets; Supply-Side Estimates; Demand-Side Estimates; Definitions and Distinctions; Revenues Versus Profits; Prices Along the Supply Chain; CHAPTER THREE: U.S. Marijuana Consumption and Mexican Drug-Trafficking Organizations' Revenues from Exporting Marijuana; Total Consumption of Marijuana in the United States

Mexican Marijuana's Share of the U.S. MarketWholesale Marijuana Prices Along the Southwest Border; Mexican Drug-Trafficking Organizations' Gross Revenues from Exporting Marijuana to the United States; CHAPTER FOUR: How Might Legalization in California Affect Mexican Drug-Traffic king Organizations' Marijuana Export Revenues?; CHAPTER FIVE: Beyond Marijuana Exports: Insights About Additional Sources of Mexican Drug- Trafficking Organizations' Drug Revenue; Assessing the Claim That 60 Percent of Mexican Drug-Trafficking Organization Drug Revenues Are from Marijuana; Background

There Is No Empirical Justification for This Figure That Can Be VerifiedSubsequent National Drug Intelligence Center Estimates Reveal Large Uncertainty About These Numbers; The 8.57 Billion Figure for Drug-Trafficking Organizations' Marijuana Revenues Is Not Credible; Exploratory Analysis of Gross Export Revenues for Other Drugs; Drug-Trafficking Organizations' Revenues from Domestic Distribution Within the United States.; Concluding Thoughts; CHAPTER SIX: How Could a Reduction in Marijuana Revenues Influence Mexican Drug-Traffi cking Organizations?

Mexican Drug-Trafficking Organizations: Activities and CapacitiesSources; Characterizing Mexican Drug-Trafficking Organizations; The Nondrug Activities of Drug-Trafficking Organizations; Analogies; General Principles; CHAPTER SEVEN: Conclusion; Bibliography; Appendix A: A New Estimate of the Weight of a Marijuana Joint; Appendix B: Delta-9-Tetrahydrocannabinol (THC) Content of Sinsemilla and Mexican Commercial-Grade Marijuana; Appendix C: Marijuana Price Data

Using the National Survey on Drug Use and Health to Estimate the Share of Marijuana Purchases That Are Sinsemilla Versus Commercial GradeProportion of Arrestee Drug Abuse Monitoring Data Purchases That Are as Expensive as Sinsemilla; Wholesale Prices Near the Southwestern U.S. Border; Export Prices; Geography-Specific Information About Marijuana Prices; Appendix D: Exploratory Analysis of Mexican Drug-Trafficking Organizations' Revenues from Other Drugs Exported to the United States

Total Spending on Cocaine, Heroin, and Methamphetamine in the United States: Judgmental Updates of Abt's Demand-Side Estimates for the Year 2000